Subcutaneous administration takes less time and is tied to fewer administration-related reactions than intravenous.
A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid ...
Implanted living skin-based biosensors offer a breakthrough in inflammation tracking, providing real-time biomarker ...
The U.S. Food and Drug Administration has approved the Zycubo (copper histidinate) injection as the first treatment for ...
The Food and Drug Administration (FDA) has approved Zycubo® (copper histidinate) for the treatment of Menkes disease in pediatric patients.
With star checkpoint inhibitors like Keytruda and Opdivo now sporting subcutaneous formulations, GSK has struck a deal aimed ...
The collaboration between ten23 health and BD aims to commercialize the BD Libertas wearable injector for large-volume ...
The SFDA is the first regulatory authority globally to grant conditional approval for this medication for the treatment of NSCLC ...
Saudi Arabia leads the way as the first country to grant conditional approval for Anktiva, a groundbreaking treatment for ...
GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE(R) natural killer (NK ...
GT Biopharma, Inc. (the "Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative ...